Juvenile dermatomyositis

被引:0
作者
Sell-Salazar, F [1 ]
机构
[1] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Neurol Serv, San Jose, Costa Rica
关键词
autoimmune vasculitis injury; idiopathic inflammatory myositis; juvenile dermatomyositis;
D O I
10.33588/rn.3402.2001302
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Juvenile dermatomyositis is part of the idiopathic inflammatory myositis group of diseases, presenting acute or chronic multisystemic inflammatory injury, that mainly affects muscles and skin. It's incidence is 411, 000, 000, prevailing in women and Caucasians, with symptoms starting between 5-14 years of age. The etiology is unknown, nevertheless is well recognized the role of vasculitis produced by autoantibodies, such is responsible for the damage on skin and muscular microvasculature. The acute or chronic complications and the neuropathic manifestations (cerebral vasculitis and peripheric neuropathy) are rare, and both are the result of the same autoimmune vasculitis injury.
引用
收藏
页码:178 / 180
页数:3
相关论文
共 50 条
  • [41] Update on the clinical management of juvenile dermatomyositis
    Huber, Adam M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 1021 - 1028
  • [42] Severe juvenile dermatomyositis complicated by pancreatitis
    See, Y
    Martin, K
    Rooney, M
    Woo, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (08): : 912 - 916
  • [43] Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update
    Morris, Paula
    Dare, Jason
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (03) : 189 - 191
  • [44] Dyslipidemia in active juvenile dermatomyositis patients
    KT Kozu
    CA Silva
    EF Borba
    AME Sallum
    VST Viana
    LMA Campos
    Pediatric Rheumatology, 9 (Suppl 1)
  • [45] Juvenile dermatomyositis: a tertiary center experience
    Kenan Barut
    Pinar Ozge Avar Aydin
    Amra Adrovic
    Sezgin Sahin
    Ozgur Kasapcopur
    Clinical Rheumatology, 2017, 36 : 361 - 366
  • [46] Juvenile dermatomyositis: A series of 22 cases
    Moegle, C.
    Lipsker, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (8-9): : 494 - 503
  • [47] Recent advances in juvenile dermatomyositis.
    Reed A.M.
    Mason T.
    Current Rheumatology Reports, 2005, 7 (2) : 94 - 98
  • [48] Medications received by patients with juvenile dermatomyositis
    Kishi, Takayuki
    Bayat, Nastaran
    Ward, Michael M.
    Huber, Adam M.
    Wu, Lan
    Mamyrova, Gulnara
    Targoff, Ira N.
    Warren-Hicks, William J.
    Miller, Frederick W.
    Rider, Lisa G.
    Abramson, Leslie S.
    Albert, Daniel A.
    Amoroso, Kathy
    Arabshahi, Bita
    Balboni, Imelda M.
    Ballinger, Susan
    Barillas, Lilliana
    Bingham, C. April
    Bohnsack, John F.
    Boire, Gilles
    Borzy, Michael S.
    Bowyer, Suzanne L.
    Carrasco, Ruy
    Chao, Chun Peng T.
    Cron, Randy Q.
    Curiel, Rodolfo
    DeGuzman, Marietta M.
    Ede, Kaleo
    Eberhard, Barbara Anne
    Finkel, Terri H.
    Fuhlbrigge, Robert C.
    Gedalia, Abraham
    George, Stephen W.
    Gewanter, Harry L.
    Goldmuntz, Ellen A.
    Goldsmith, Donald P.
    Gottlieb, Beth
    Griffin, Thomas A.
    Haftel, Hilary M.
    Hannan, William
    Hawkins, Melissa
    Hennon, Teresa
    Henrickson, Michael
    Higgins, Gloria C.
    Hollister, J. Roger
    Hopp, Russell J.
    Imundo, Lisa
    Jacobs, Jerry C.
    Jansen, Anna
    Jarvis, James
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) : 513 - 522
  • [49] Autoantibody Profile of Children with Juvenile Dermatomyositis
    Avinash Sharma
    Dharmagat Bhattarai
    Anju Gupta
    Sandesh Guleria
    Amit Rawat
    Pandiarajan Vignesh
    Ravinder Garg
    Surjit Singh
    Indian Journal of Pediatrics, 2021, 88 : 1170 - 1173
  • [50] Immunoglobulin A nephropathy associated with juvenile dermatomyositis
    Mahmut Civilibal
    Nilgun Selcuk Duru
    Aysim Ozagari
    Kemal Durali
    Murat Elevli
    Pediatric Nephrology, 2009, 24 : 2073 - 2075